| ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia M Crespo, F Bosch, N Villamor, B Bellosillo, D Colomer, M Rozman, ... New England Journal of Medicine 348 (18), 1764-1775, 2003 | 1732 | 2003 |
| The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma A Rosenwald, G Wright, A Wiestner, WC Chan, JM Connors, E Campo, ... Cancer cell 3 (2), 185-197, 2003 | 1075 | 2003 |
| Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations K Stamatopoulos, C Belessi, C Moreno, M Boudjograh, G Guida, ... Blood 109 (1), 259-270, 2007 | 664 | 2007 |
| Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma L Colomo, A López-Guillermo, M Perales, S Rives, A Martınez, F Bosch, ... Blood, The Journal of the American Society of Hematology 101 (1), 78-84, 2003 | 641 | 2003 |
| Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution J Bladé, P Fernández-Llama, F Bosch, J Montolíu, XM Lens, S Montoto, ... Archives of internal medicine 158 (17), 1889-1893, 1998 | 584 | 1998 |
| Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer C Montagut, A Dalmases, B Bellosillo, M Crespo, S Pairet, M Iglesias, ... Nature medicine 18 (2), 221-223, 2012 | 537 | 2012 |
| Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma V Fernàndez, O Salamero, B Espinet, F Solé, C Royo, A Navarro, ... Cancer research 70 (4), 1408-1418, 2010 | 531 | 2010 |
| Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors F Bosch, A López‐Guillermo, E Campo, JM Ribera, E Conde, MA Piris, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1998 | 463 | 1998 |
| Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium N Rothman, CF Skibola, SS Wang, G Morgan, Q Lan, MT Smith, ... The lancet oncology 7 (1), 27-38, 2006 | 435 | 2006 |
| PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma F Bosch, P Jares, E Campo, A Lopez-Guillermo, MA Piris, N Villamor, ... | 434 | 1994 |
| Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin A López-Guillermo, L Colomo, M Jiménez, F Bosch, N Villamor, ... Journal of clinical oncology 23 (12), 2797-2804, 2005 | 381 | 2005 |
| Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants S Beà, M Ribas, JM Hernández, F Bosch, M Pinyol, L Hernández, ... Blood, The Journal of the American Society of Hematology 93 (12), 4365-4374, 1999 | 361 | 1999 |
| PRAD-1/Cyclin D1 Gene Amplification Correlates with Messenger RNA Overexpression and Tumor Progression in Human Laryngeal Carcinomas P Jares, PL Fernández, E Campo, A Nadal, F Bosch, G Aiza, I Nayach, ... Cancer research 54 (17), 4813-4817, 1994 | 353 | 1994 |
| Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the REAL Classification A Lopez-Guillermo, J Cid, A Salar, A Lopez, C Montalban, JM Castrillo, ... Annals of Oncology 9 (8), 849-855, 1998 | 345 | 1998 |
| The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL IW Flinn, P Hillmen, M Montillo, Z Nagy, Á Illés, G Etienne, J Delgado, ... Blood, The Journal of the American Society of Hematology 132 (23), 2446-2455, 2018 | 343 | 2018 |
| The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in … CM Wheeler, SK Kjaer, K Sigurdsson, OE Iversen, M Hernandez-Avila, ... The Journal of infectious diseases 199 (7), 936-944, 2009 | 342 | 2009 |
| p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas L Hernandez, T Fest, M Cazorla, J Teruya-Feldstein, F Bosch, ... | 341 | 1996 |
| Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma. A Lopez-Guillermo, E Montserrat, F Bosch, MJ Terol, E Campo, ... Journal of Clinical Oncology 12 (7), 1343-1348, 1994 | 265 | 1994 |
| A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European … AC Rawstron, C Fazi, A Agathangelidis, N Villamor, R Letestu, ... Leukemia 30 (4), 929-936, 2016 | 264 | 2016 |
| Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia F Bosch, A Ferrer, A López‐Guillermo, E Giné, B Bellosillo, N Villamor, ... British journal of haematology 119 (4), 976-984, 2002 | 246 | 2002 |
